Repeated infusions of escalating doses of expanded and activated autologous natural killer cells in minimal residual disease-positive Ph plus acute lymphoblastic leukemia patients. A GIMEMA phase 1 trial
AMERICAN JOURNAL OF HEMATOLOGY(2022)
Key words
acute lymphoblastic leukemia,natural killer cells,leukemia patients,escalating doses,gimema phase,disease-positive
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined